CA975297A - Pharmaceutical composition containing a high percentage of allopurinol - Google Patents

Pharmaceutical composition containing a high percentage of allopurinol

Info

Publication number
CA975297A
CA975297A CA185,010A CA185010A CA975297A CA 975297 A CA975297 A CA 975297A CA 185010 A CA185010 A CA 185010A CA 975297 A CA975297 A CA 975297A
Authority
CA
Canada
Prior art keywords
allopurinol
pharmaceutical composition
composition containing
high percentage
percentage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA185,010A
Inventor
Allan J. Torode
Henry J. Kessler
David Harden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA975297A publication Critical patent/CA975297A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
CA185,010A 1972-11-06 1973-11-05 Pharmaceutical composition containing a high percentage of allopurinol Expired CA975297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
CA975297A true CA975297A (en) 1975-09-30

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
CA185,010A Expired CA975297A (en) 1972-11-06 1973-11-05 Pharmaceutical composition containing a high percentage of allopurinol

Country Status (14)

Country Link
JP (1) JPS577127B2 (en)
AU (1) AU467532B2 (en)
BE (1) BE806946A (en)
CA (1) CA975297A (en)
CH (1) CH583734A5 (en)
CY (1) CY940A (en)
DE (1) DE2355204A1 (en)
FR (1) FR2205309B1 (en)
GB (1) GB1445983A (en)
HK (1) HK1278A (en)
IL (1) IL43562A (en)
KE (1) KE2807A (en)
MY (1) MY7800180A (en)
ZA (1) ZA738489B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (en) * 1986-12-12 1990-03-02 Chauvin Laboratoires USE OF XANTHINE OXIDASE INHIBITORS, OXYGEN FREE RADIAL TRAPERS AND IRON CHELATORS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
HK1278A (en) 1978-01-13
IL43562A0 (en) 1974-03-14
JPS577127B2 (en) 1982-02-09
KE2807A (en) 1978-02-17
CH583734A5 (en) 1977-01-14
BE806946A (en) 1974-05-06
FR2205309A1 (en) 1974-05-31
DE2355204A1 (en) 1974-05-16
MY7800180A (en) 1978-12-31
GB1445983A (en) 1976-08-11
JPS49133517A (en) 1974-12-21
CY940A (en) 1978-06-23
AU6217773A (en) 1975-05-08
IL43562A (en) 1976-08-31
FR2205309B1 (en) 1976-04-09
ZA738489B (en) 1975-02-26
AU467532B2 (en) 1975-12-04

Similar Documents

Publication Publication Date Title
CA1003752A (en) Pharmaceutical compositions
CA1009150A (en) Pharmaceutical compositions containing cysteine derivatives
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
AU475599B2 (en) Pharmaceutical compositions
MY7700009A (en) Pharmaceutical compositions containing bischromonyloxy compounds
CA977279A (en) Tablet formulation containing a high percentage of allopurinol
CA975297A (en) Pharmaceutical composition containing a high percentage of allopurinol
AU476390B2 (en) Pharmaceutical composition
AU475517B2 (en) Pharmaceutical compositions containing salts of sulfoglycopeptides with a minoacids
AU5915973A (en) Pharmaceutical compositions
IL41564A0 (en) Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives
AU471794B2 (en) Iodophor-steroid pharmaceutical compositions
CA1006816A (en) Pharmaceutical compositions
CA979808A (en) Pharmaceutical composition containing 4-hydroxynicotinic acid
CA897066A (en) Aerosol composition
AU478574B2 (en) Pharmaceutical composition
CA900357A (en) Pharmaceutical composition
CA899777A (en) Pharmaceutical compositions
CA892542A (en) Pharmaceutical compositions
AU474663B2 (en) Pharmaceutical compositions
CA907516A (en) Pharmaceutical compositions
CA900356A (en) Pharmaceutical compositions
CA910906A (en) Pharmaceutical compositions
CA896528A (en) Pharmaceutical compositions
AU472192B2 (en) Pharmaceutical compositions